Marché mondial du traitement des troubles de la paraphilie – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et perspectives du marché mondial du traitement des troubles de la paraphilie

Le marché du traitement des troubles de la paraphilie devrait connaître une croissance du marché au cours de la période de prévision 2022-2029. Data Bridge Market Research analyse le marché pour s'attendre à une croissance à un TCAC de 7,10 % au cours de la période de prévision mentionnée ci-dessus.

Les paraphilies sont des désirs, des envies, des fantasmes ou des comportements sexuels persistants et récurrents, impliquant des objets, des activités ou même des situations anormales par nature. Un trouble paraphilique peut se développer si la paraphilie provoque des souffrances, une détresse ou une altération fonctionnelle dans la vie des personnes concernées ou d'autres personnes, même si elle n'est pas intrinsèquement anormale. La pédophilie, l'exhibitionnisme, le voyeurisme, le sadisme sexuel, le masochisme sexuel, le frotteurisme, le fétichisme et le fétichisme travesti font partie des huit paraphilies classées dans le DSM V.

L'augmentation de la prévalence des troubles de la paraphilie constituera un moteur majeur qui entraînera l'expansion de la croissance du marché. Un autre facteur important influençant le taux de croissance du marché du traitement des troubles de la paraphilie est l'augmentation des dépenses de santé. En outre, les progrès de la technologie médicale, les initiatives croissantes des organisations publiques et privées pour sensibiliser et le financement croissant du gouvernement sont les facteurs qui élargiront le marché du traitement des troubles de la paraphilie. D'autres facteurs tels que l'augmentation de la demande de thérapies efficaces et l'augmentation de la population gériatrique auront un impact positif sur le taux de croissance du marché du traitement des troubles de la paraphilie. De plus, le revenu disponible élevé et l'évolution du mode de vie entraîneront l'expansion du marché du traitement des troubles de la paraphilie.

Moreover, the rise in the research and development activities and launch of effective therapies will provide beneficial opportunities for the paraphilia disorder treatment market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate paraphilia disorder treatment market in future.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of paraphilia disorder treatment market. Additionally, complications involved with this disease will hinder the paraphilia disorder treatment market growth. Less awareness will further challenge the market in the forecast period mentioned above.

This paraphilia disorder treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Paraphilia disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Paraphilia Disorder Treatment Market Scope and Market Size

The paraphilia disorder treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the paraphilia disorder treatment market is segmented into pedophilia, exhibitionism, voyeurism, sexual sadism, sexual masochism, frotteurism, fetishism, and transvestic fetishism.
• On the basis of treatment, the paraphilia disorder treatment market is segmented into medication, cognitive behavioral therapy and others. The segment of medication is further sub-segmented into selective serotonin re-uptake inhibitors (SSRIs) and others. The segment selective serotonin re-uptake inhibitors (SSRIs) is divided into fluoxetine, sertraline, paroxetine, citalopram, escitalopram and vortioxetine.
• On the basis of diagnosis, the paraphilia disorder treatment market is segmented into physical examination, imaging tests, laboratory tests and others. The segment of imaging tests is further sub-segmented into ultrasonography and angiography.
• On the basis of dosage, the paraphilia disorder treatment market is segmented into injection, tablets and others.
• On the basis of route of administration, the paraphilia disorder treatment market is segmented into oral, intravenous and others.
• On the basis of end-users, the paraphilia disorder treatment market is segmented into clinic, hospital and others.

The paraphilia disorder treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Paraphilia Disorder Treatment Market Country Level Analysis

Paraphilia disorder treatment market is analyzed and market size information is provided by the country, type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the paraphilia disorder treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the paraphilia disorder treatment market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Paraphilia disorder treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Paraphilia Disorder Treatment Market Share Analysis

Le paysage concurrentiel du marché du traitement des troubles de la paraphilie fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais cliniques, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée à l'étude de marché sur le traitement des troubles de la paraphilie.

Français Certains des principaux acteurs opérant sur le marché du traitement des troubles de la paraphilie sont Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, AbbVie Inc., Eisai Co., Ltd., Pfizer Inc., GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan NV, Allergan, Sun Pharmaceutical Industries Ltd., Sanofi, Aurobindo Pharma, Cipla Inc., Abbott, Merck & Co., Inc., Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd., AstraZeneca, WOCKHARDT et Echo Pharmaceuticals BV, entre autres.

SKU-67811